000 | 01644 a2200469 4500 | ||
---|---|---|---|
005 | 20250517071019.0 | ||
264 | 0 | _c20161017 | |
008 | 201610s 0 0 eng d | ||
022 | _a1361-6528 | ||
024 | 7 |
_a10.1088/0957-4484/27/6/065101 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClark, Andrea J | |
245 | 0 | 0 |
_aWO3/Pt nanoparticles are NADPH oxidase biomimetics that mimic effector cells in vitro and in vivo. _h[electronic resource] |
260 |
_bNanotechnology _cFeb 2016 |
||
300 |
_a065101 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBiomimetics _xmethods |
650 | 0 | 4 |
_aCatalysis _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHydroxyl Radical _xchemistry |
650 | 0 | 4 | _aLight |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aNADPH Oxidases _xmetabolism |
650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 |
_aOxides _xpharmacology |
650 | 0 | 4 |
_aPhotochemotherapy _xmethods |
650 | 0 | 4 |
_aPhotosensitizing Agents _xpharmacology |
650 | 0 | 4 |
_aPlatinum _xpharmacology |
650 | 0 | 4 |
_aTungsten _xpharmacology |
700 | 1 | _aCoury, Emma L | |
700 | 1 | _aMeilhac, Alexandra M | |
700 | 1 | _aPetty, Howard R | |
773 | 0 |
_tNanotechnology _gvol. 27 _gno. 6 _gp. 065101 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1088/0957-4484/27/6/065101 _zAvailable from publisher's website |
999 |
_c25556582 _d25556582 |